1. Home
  2. PODD vs FWONK Comparison

PODD vs FWONK Comparison

Compare PODD & FWONK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • FWONK
  • Stock Information
  • Founded
  • PODD 2000
  • FWONK 1950
  • Country
  • PODD United States
  • FWONK United States
  • Employees
  • PODD N/A
  • FWONK N/A
  • Industry
  • PODD Medical/Dental Instruments
  • FWONK Broadcasting
  • Sector
  • PODD Health Care
  • FWONK Industrials
  • Exchange
  • PODD Nasdaq
  • FWONK Nasdaq
  • Market Cap
  • PODD 19.0B
  • FWONK 21.4B
  • IPO Year
  • PODD 2007
  • FWONK N/A
  • Fundamental
  • Price
  • PODD $258.75
  • FWONK $88.93
  • Analyst Decision
  • PODD Buy
  • FWONK Buy
  • Analyst Count
  • PODD 17
  • FWONK 6
  • Target Price
  • PODD $294.65
  • FWONK $97.17
  • AVG Volume (30 Days)
  • PODD 880.6K
  • FWONK 1.4M
  • Earning Date
  • PODD 05-08-2025
  • FWONK 05-07-2025
  • Dividend Yield
  • PODD N/A
  • FWONK N/A
  • EPS Growth
  • PODD 96.55
  • FWONK N/A
  • EPS
  • PODD 5.78
  • FWONK N/A
  • Revenue
  • PODD $2,071,600,000.00
  • FWONK $3,620,000,000.00
  • Revenue This Year
  • PODD $20.58
  • FWONK $15.75
  • Revenue Next Year
  • PODD $17.41
  • FWONK $7.18
  • P/E Ratio
  • PODD $44.73
  • FWONK N/A
  • Revenue Growth
  • PODD 22.07
  • FWONK 12.35
  • 52 Week Low
  • PODD $160.19
  • FWONK $64.37
  • 52 Week High
  • PODD $289.46
  • FWONK $102.33
  • Technical
  • Relative Strength Index (RSI)
  • PODD 44.69
  • FWONK 47.04
  • Support Level
  • PODD $258.25
  • FWONK $85.53
  • Resistance Level
  • PODD $276.13
  • FWONK $90.51
  • Average True Range (ATR)
  • PODD 8.60
  • FWONK 2.04
  • MACD
  • PODD 0.94
  • FWONK 0.50
  • Stochastic Oscillator
  • PODD 55.53
  • FWONK 78.73

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it world-wide.

About FWONK Liberty Media Corporation Series C Liberty Formula One

Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.

Share on Social Networks: